ArticleDiscover oncology2025
Occult breast cancer with CSF TBA positivity and abnormal involuntary movements.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Occult breast cancer (OBC) is a rare and special type of breast cancer. The initial symptom is an enlarged axillary lymph node. Paraneoplastic neurological syndromes (PNS) are a group of syndromes that are caused by malignant tumors and damage to the nervous system in distant parts. Most patients have neurological symptoms before the primary tumors. Early diagnosis and treatment are beneficial to improve the therapeutic effect of patients. This case report describes a 54-year-old woman presenting with a one-year history of gradual-onset abnormal involuntary movements, psychiatric disorders, mental decline, and weight loss. Neurological evaluation showed that delirium, involuntary movements and muscle tension increased. Although extensive diagnostic tests were carried out, including routine and biochemical analyses of cerebrospinal fluid (CSF) and hematological examinations, no obvious abnormalities were detected except that the antinuclear antibody and tissue-based analysis (TBA) in serum and CSF were positive. Initial treatments, including glucocorticoid, antiviral therapy and immunoglobulin, were ineffective. Further systemic ultrasonography and positron emission tomography revealed enlarged hyper-metabolic lymph nodes in the right axillary and bilateral sub mental regions. Pathological examination confirmed adenocarcinoma infiltration, consistent with breast origin, leading to a diagnosis of OBC and PNS. Combination therapy was initiated with palbociclib (CDK4/6 inhibitor) plus letrozole (aromatase inhibitor), which led to the gradual improvement of involuntary movements, although cognitive impairment and indifference still existed. This case highlights the diagnostic challenges of OBC and PNS, emphasizing the importance of comprehensive diagnostic approaches and the potential for neurological symptoms to precede tumor detection. To our knowledge, this is a rare case of OBC with TBA positivity presenting with parkinsonism and cognitive disorder, contributing to the understanding of PNS complexity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.